Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Nephrology
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ach-4471 | ACHILLION PHARMACEUTICALS INC (ACHN) |
Frequently asked questions
How many drugs are in development for Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)?
BioSniper tracks 1 drug in development for Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) across 1 company.
How many clinical trials target Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)?
There are 4 clinical trials targeting Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) tracked by BioSniper.
Deep-dive into Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis